Best Biopharma Outsourcing Companies in Pennsylvania, United States
The 172 best Biopharma Outsourcing companies in Pennsylvania, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Center for Breakthrough Medicines.
Our analysis of 50 Biopharma Outsourcing companies
$6.3b in tracked funding; 77% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in Pennsylvania
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Center for Breakthrough Medicines Provider of process & analytical development and research services | $350M | 53 mo ago | 311 | 2015 | — | — | — | — |
| 2 | United BioSource Corporation Uniting evidence and access to improve patient outcomes for biopharma | $278M | 191 mo ago | 1,887 | 2003 | — | Top 5M | — | — |
| 3 | ClinChoice CRO focused on data management, regulatory affairs and consulting services | $212M | 47 mo ago | 478 | 1995 | John Balian Co-Founder & CEO | Top 5M | — | — |
| 4 | PCI Provider of clinical & commercial supply chain and packaging solutions 84Funding top 22%Tech top 24%Innovation top 25%Product top 30% All 8 signals ▾Fundingtop 22% Techtop 24% Innovationtop 25% Producttop 30% Growthtop 35% Markettop 38% Talentbottom 49% Globalbottom 38% Funding: Raised $205M across 1 rounds · 1 rounds over 14 yrs (0.1/yr) Tech: 48 technologies across 5/8 capability areas · Cloud: Amazon Ses, Amazon Web Services rank vs industry peers · Fliar Intelligence Index 84/100 | $205M | 11 mo ago | 4,300 | 1997 | Salim Haffar CEO | Top 5M | — | 2 expansions |
| 5 | VintaBio Life sciences company specializing in alleviating the viral vector bottleneck in cell and gene therapy… | $64M | 38 mo ago | 17 | 2020 | Shangzhen Zhou Co-Founder | — | — | — |
| 6 | Fox Chase Chemical Diversity Center Provider of drug discovery services | $44M | 45 mo ago | 27 | 2008 | — | — | — | — |
| 7 | CoJourney CDMO focused on manufacturing mRNA & plasmids and regulatory services | $30M | 35 mo ago | 4 | 2021 | — | Top 5M | — | — |
| 8 | Acurian Clinical trial patient enrollment and retention solutions | $27M | 302 mo ago | 263 | 1998 | — | — | — | — |
| 9 | BioPharm Communications Provider of marketing services to pharmaceutical and biopharma companies | $18M | 170 mo ago | 37 | 2005 | — | Top 50M | — | 1 award |
| 10 | BlueWhale Provider of cell & gene therapies development and research services 45Growth top 28%Funding top 38%Talent top 38%Tech top 43% All 7 signals ▾Growthtop 28% Fundingtop 38% Talenttop 38% Techtop 43% Newstop 46% Globalbottom 36% Marketbottom 22% Growth: Web rank 50,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo Funding: Raised $18.0M across 2 rounds · 2 rounds over 3 yrs (0.7/yr) rank vs industry peers · Fliar Intelligence Index 45/100 | $18M | 8 mo ago | — | 2022 | Carl June Founder | Top 10M | — | — |
| 11 | Invisible Sentinel Provider of technology for food supply safety | $18M | 110 mo ago | 40 | 2006 | — | — | 96 patents Patents concentrated in computing, sensing & instrumentation | — |
| 12 | The One Health CRO providing clinical validation at the preclinical stage focused on pets | $17M | 67 mo ago | 34 | 2014 | — | — | — | 1 award |
| 13 | Cellumen Biomarkers, antibodies, assay kits, and reagents for life science research | $12M | 195 mo ago | 7 | 2004 | Lans Taylor CEO | — | 27 patents AI-driven automated tissue analysis and cellular interaction biosensor platforms for predictive biology | — |
| 14 | Frontage Laboratories Global pharmaceutical development organization providing comprehensive drug discovery and development services | $10M | 217 mo ago | 1,613 | 2001 | Song Li CEO | Top 5M | — | — |
| 15 | Frontida BioPharm Contract development and manufacturing services for small molecules | $8M | 118 mo ago | 243 | 2016 | Song Li CEO | — | — | — |
| 16 | Conifer Point Developer of new drugs using custom fragment-based drug design software | $7M | 12 mo ago | 5 | 2015 | — | — | — | — |
| 17 | IndiPharm Clinical Research CRO offering clinical development services from Phases I to IV | $5M | 134 mo ago | — | 2007 | Edward Brennon President & CEO | — | — | — |
| 18 | Benten BioServices Contract services organization for biopharmaceutical products | $5M | 157 mo ago | 16 | 2008 | — | — | — | — |
| 19 | Tavanta Developer of drug for debilitating multiple medical conditions | $4M | 173 mo ago | 12 | 2011 | Lynne Powell CEO | — | — | — |
| 20 | FlowMetric CRO offers preclinical, data analysis, clinical testing, and other services | $4M | 84 mo ago | 52 | 2010 | Renold Capocasale Founder & CEO | — | — | — |
| 21 | MODA Technology Partners Provider of drug research and development and custom manufacturing services | $2M | 239 mo ago | 38 | 2005 | — | — | — | — |
| 22 | IntegriChain Pharma commercialization solutions: data, consulting, and technology for market access | $2M | 123 mo ago | 320 320 → 731 (+128%) | 2005 | Joshua Halpern Co-Founder & CEO | Top 5M | — | 1 job opening |
| 23 | KinderPharm CRO for pediatric drug development also offering formulation development services for pediatrics | $1M | 130 mo ago | 11 | 2014 | — | — | — | — |
| 24 | Pharma Resource Group Provider of product development, manufacturing, and consultancy services for pharmaceutical, biotech, and… | $825K | 15 mo ago | 62 | 2007 | James Corrado Co-Founder & COO | — | — | — |
| 25 | InClinica Clinical CRO specializing in first in man and phase 2 studies. | $375K | 92 mo ago | 9 | 2016 | — | — | — | — |
| 26 | Incite Health Clinical laboratory specializing in immune system testing and pharmacogenomics services for clinical trials | $331K | 13 mo ago | — | 2014 | Julie Bick Co-Founder & Chief Scientific Officer Incite Health | Top 50M | — | — |
| 27 | Eunoia Biotech Preclinical-stage drug delivery company developing advanced technologies for disease treatment | $300K | 118 mo ago | — | 2013 | Kenny Roberts Founder & CEO | — | — | — |
| 28 | Pharmula Laboratories Developer and manufacturer of APIs as well as finished products | $100K | 101 mo ago | — | 2014 | Lijuan Tang CEO | — | — | — |
| 29 | US Specialty Formulations API processing and manufacturing of sterile injectable solutions | $100K | 143 mo ago | — | 2013 | Kyle Y Flanigan CEO | — | — | — |
Top 12 Biopharma Outsourcing companies in Pennsylvania
#1
Late Stage · Philadelphia, Pennsylvania · founded 1997 · 4300 employees$205Mraised▾
Provider of clinical & commercial supply chain and packaging solutions
- Jul 2025PE—
- 2016PE—
- May 2013Conventional Debt$205M
- 2012PE—
#2
Series A · Philadelphia, Pennsylvania · founded 2022$18Mraised▾
Provider of cell & gene therapies development and research services
- Oct 2025Series A$5M
- Sep 2023Seed$18M
#3
Acquired · Doylestown, Pennsylvania · founded 2015 · 5 employees$7.4Mraised▾
Developer of new drugs using custom fragment-based drug design software. Services offered include molecular dynamics simulations, quantum mechanical simulations, hot-spot mapping, and water mapping. The pipeline includes renin and DHFR in a hit to lead stage for hypertension and gram-negative bacteria, d-ala-d-ala ligase for tuberculosis and gram-negative bacteria in the hit validation stage, and PD-1 for immuno-oncology in the computational chemistry stage
- Jun 2025Grant (prize money)$2.6M
- Jul 2020Grant (prize money)$2.9M
- Jun 2016Grant (prize money)$1.8M
#4
Acquired · Royersford, Pennsylvania · founded 2007 · 62 employees$825Kraised▾
Provider of product development, manufacturing, and consultancy services for pharmaceutical, biotech, and related sectors. It offers a full suite of services encompassing the entire product lifecycle, from initial concept and innovation through to commercial manufacturing. The company assists clients in navigating regulatory hurdles, optimizing resource allocation, and achieving commercial viability. A state-of-the-art facility supports product development and GMP commercial manufacturing. Consultancy services are tailored to meet specific client needs, integrating seamlessly with existing project workflows. The firm provides expertise and resources at any project phase, minimizing cost and time overruns.
- Mar 2025Seed$825K
#5
Seed · Doylestown, Pennsylvania · founded 2014$330.7Kraised▾
Incite Health is a clinical laboratory that specializes in immune system testing and pharmacogenomics services to improve the safety, efficacy, and efficiency of clinical trials. The company provides innovative pharmacogenetic insights relevant to health and personalized health plans through simple testing. Incite Health is a CLIA-certified, CAP-accredited, high complexity clinical laboratory at the forefront of healthcare innovation.
- May 2025Seed$330.7K
#6
Series E · Fort Washington, Pennsylvania · founded 1995 · 478 employees$212Mraised▾
CRO focused on data management, regulatory affairs and consulting services
- Jul 2022Series E$150M
- Oct 2019Series D$62M
#7
Acquired · King Of Prussia, Pennsylvania · founded 2015 · 311 employees$350Mraised▾
Provider of process & analytical development and research services
- Jan 2022Series D$350M
#8
Series C · Philadelphia, Pennsylvania · founded 2020 · 17 employees$64Mraised▾
It is a life sciences company that specializes in alleviating the viral vector bottleneck in cell and gene therapy development. They provide cell and gene therapy manufacturing services to pharmaceutical, biotechnology, academic, and government organizations.
- Apr 2023Series C$64M
#9
Series A · Ambler, Pennsylvania · founded 2021 · 4 employees$30Mraised▾
CDMO focused on manufacturing mRNA & plasmids and regulatory services
- Jul 2023Series A$30M
#10
Funding Raised · Doylestown, Pennsylvania · founded 2008 · 27 employees$43.8Mraised▾
Provider of drug discovery services
- Aug 2022Grant (prize money)$598.9K
- Aug 2022Grant (prize money)$598.1K
- Apr 2021Grant (prize money)$1.6M
- Jul 2020Grant (prize money)$3M
#11
Acquired · Blue Bell, Pennsylvania · founded 2003 · 1887 employees$278Mraised▾
Uniting evidence and access to improve patient outcomes for biopharma. They connect specialty therapies to patients through customized solutions in access, safety, and evidence generation. They partner with biopharma to modernize evidence development and patient access pathways, ensuring therapies are safe, effective, and available. They integrate real-world evidence, risk management, and understanding of the patient journey to transform how therapies reach patients. Their solutions leverage expertise, real-world data, and technologies to demonstrate product value and support better outcomes. Services include evidence generation, modernized study design, late-stage research, safety and risk management, pharmacovigilance, and patient access solutions like affordability and adherence programs. They offer expert-led solutions to guide program design and delivery, from study designs to late-stage research, aligning with patient, provider, regulator, and payer expectations. They provide tailored drug safety and global risk management solutions, optimizing pharmacovigilance and ensuring informed decisions. They integrate high-tech and high-touch care for patient access, addressing payer
- Jul 2010Conventional Debt$150M
- Oct 2009PE$125M
- Dec 2003PE$153M
#12
Series A · Philadelphia, Pennsylvania · founded 2014 · 34 employees$16.5Mraised▾
One Health teams up with pets and their owners to provide humane contract research for pharma companies with a goal of saving both human and animal lives. The One Health Company is a Health IT company that makes animal testing more humane and predictive. It do this by connecting already sick pets to pre-clinical trials, providing ill animals access to cutting edge therapies. One Health’s validated premise is that naturally sick pets mimic naturally sick humans better than artificially sick laboratory animals. It reduces human clinical trial failures because their models have higher translational fidelity ensuring minimal false positives and negatives. The NIH has published that their methodology significantly lowers the cost of drug development.
- Oct 2020Series A$10M
- Jan 2019Seed$5M
- 2018Seed$150K
- Feb 2017Seed$815K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology in Pennsylvania is moving
A read on the academic research around Biotechnology in Pennsylvania — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 132 papers.
University of Pennsylvania and Penn State lead Pennsylvania's biotechnology research, focusing optimistically on CAR-T cell therapy and gene delivery, with recent work surging since 2020.
- University of Pennsylvania76
- Pennsylvania State University52
- California University of Pennsylvania8
- Hospital of the University of Pennsylvania2
- Messenger RNA1→6
- Translation (biology)1→3
- In vivo1→3
- Gene2→4
- Agriculture3
- Processivity2
- Proliferating cell nuclear antigen2
- Clamp2
- DNA polymerase2
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.